AI tool to help diagnose precancerous colon polyps
Part of Cancer, Digestive system clinical trials.
This trial tests an artificial intelligence system that helps doctors find and diagnose tubular adenomas (a type of precancerous polyp) during colonoscopy. It may improve early detection of colorectal cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are scheduled for a colonoscopy
- You have not had past abdominal or pelvic surgery or radiation
- You do not have active bleeding in your lower digestive tract
- You are not pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a smart computer program (artificial intelligence) can help doctors find more polyps during a standard colonoscopy for colorectal cancer screening. It may improve detection of early signs of cancer.
This study tests whether an artificial intelligence program can help doctors better identify small colon polyps (growths) during a colonoscopy, potentially avoiding unnecessary removal and improving accuracy.
This study tests whether artificial intelligence can help doctors find polyps or other issues during a colonoscopy. It may lead to better detection and earlier treatment.
This trial tests a computer-assisted measurement system during a colonoscopy to see if it can more accurately measure polyps. You might consider this if you are scheduled for a routine colonoscopy for screening or monitoring.
This trial uses artificial intelligence to help doctors better identify and classify polyps during a routine colonoscopy. It may lead to more accurate detection and fewer missed abnormalities.
This trial uses artificial intelligence to help better identify polyps during a colonoscopy, which could improve diagnosis and treatment decisions.
Hear when a new Colorectal Adenoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.